Quick Takeaways
- WASATCH ADVISORS LP filed SCHEDULE 13G/A for Journey Medical Corp Common Stock (DERM).
- Disclosed ownership: 6.7%.
- Date of event: 30 Jun 2025.
WASATCH ADVISORS LP - 30 Jun 2025 SCHEDULE 13G/A Report for Journey Medical Corp Common Stock (DERM)
- Filing Manager
- WASATCH ADVISORS LP
- Reporting Manager
- WASATCH ADVISORS LP
- Security
- Journey Medical Corp Common Stock
- Symbol
- DERM
- Shares outstanding
- 17,194,910 shares
- Disclosed Ownership
- 1,152,059 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 13:21:12 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 13 May 2025
- Next filing
- 06 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"WASATCH ADVISORS LP disclosed 6.7% ownership in Journey Medical Corp Common Stock (DERM) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 13 May 2025.
- Current filing was accepted on 14 Aug 2025, 13:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 6.7% | 1,152,059 | 1,045,193 | 0 | Mike Yeates | CEO |